Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 134,553,130
- Total 13F shares
- 35,963,686
- Share change
- -10,367,233
- Total reported value
- $11,861,338
- Put/Call ratio
- 0%
- Price per share
- $0.33
- Number of holders
- 69
- Value change
- -$3,392,024
- Number of buys
- 32
- Number of sells
- 48
Quarterly Holders Quick Answers
What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690469101:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
5.6%
|
7,531,996
|
$2,349,805 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13F
13D/G
|
Company |
0.67%
from 13D/G
|
5,315,969
|
$1,658,051 | — | 31 Mar 2025 | |
| Amit Rakhit PoA |
3/4/5
|
President and CMO |
—
mixed-class rows
|
817,806
mixed-class rows
|
$1,562,669 | — | 14 Jul 2021 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1.9%
from 13D/G
|
3,859,582
|
$1,203,804 | — | 31 Mar 2025 | |
| BVF INC/IL |
13F
|
Company |
2.9%
|
3,853,818
|
$1,202,006 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
3,108,781
|
$969,941 | — | 31 Mar 2025 | |
| Madison Avenue Partners, LP |
13D/G
13F
|
Company |
4%
|
2,852,352
|
$969,800 | $0 | 31 Dec 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.7%
|
2,232,000
|
$696,161 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
2,088,046
|
$650,000 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,732,865
|
$540,481 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,400,191
|
$436,720 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
1,372,108
|
$427,960 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.99%
|
1,330,993
|
$415,192 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.9%
|
1,208,624
|
$376,970 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.85%
|
1,150,000
|
$358,685 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.76%
|
1,023,800
|
$319,323 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.58%
|
786,547
|
$245,324 | — | 31 Mar 2025 | |
| TLS Advisors LLC |
13F
|
Company |
0.51%
|
680,967
|
$213,000 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.5%
|
667,516
|
$208,198 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.42%
|
560,830
|
$174,923 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.33%
|
440,103
|
$137,000 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.31%
|
423,618
|
$132,127 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
367,974
|
$114,772 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.2%
|
265,491
|
$82,807 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.16%
|
215,060
|
$67,077 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.15%
|
200,593
|
$62,565 | — | 31 Mar 2025 | |
| Jason Tardio |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
196,875
mixed-class rows
|
$60,469 | — | 22 Feb 2024 | |
| Thomas M. Perone Poa |
3/4/5
|
General Counsel, Secretary |
—
mixed-class rows
|
196,875
mixed-class rows
|
$60,469 | — | 22 Feb 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
165,763
|
$51,702 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
135,487
|
$42,258 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.09%
|
119,113
|
$37,151 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.09%
|
115,867
|
$36,139 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.08%
|
105,177
|
$32,605 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
104,435
|
$32,573 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.07%
|
97,000
|
$30,254 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
95,434
|
$29,766 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
93,154
|
$29,055 | — | 31 Mar 2025 | |
| Empowered Funds, LLC |
13F
|
Company |
0.07%
|
91,234
|
$28,456 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
83,084
|
$25,914 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
82,727
|
$25,802 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
80,917
|
$25,240 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.05%
|
66,953
|
$20,883 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
63,918
|
$19,936 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
47,780
|
$14,903 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
44,010
|
$13,727 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
43,197
|
$13,473 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
43,028
|
$13,000 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
37,012
|
$11,544 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
31,750
|
$9,874 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.02%
|
30,896
|
$9,636 | — | 31 Mar 2025 |
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q2 2025
As of 30 Jun 2025,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,963,686 shares.
The largest 10 holders included
TAKEDA PHARMACEUTICAL CO LTD, BVF INC/IL, VANGUARD GROUP INC, Sio Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, KENNEDY CAPITAL MANAGEMENT LLC, Driehaus Capital Management LLC, BlackRock, Inc., and Madison Avenue Partners, LP.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
81
Q2 2025 holders
69
Holder diff
-12
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.